Live Breaking News & Updates on Owned Gene Therapy Manufacturing Facility

Stay updated with breaking news from Owned gene therapy manufacturing facility. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MeiraGTx Announces Third Quarter 2023 Financial and Operational Results

MeiraGTx Announces Third Quarter 2023 Financial and Operational Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , City Of , Jason Braco , Wachtell Lipton , Meiragtx Riboswitch , Lifesci Communications , Janssen Pharmaceuticals Inc , Meiragtx Holdings , Program Oral Presentation , Congress On , European Society Of Gene , Central Nervous System , European Society , Cell Therapy , Commercial Manufacturer , Quality Control , Alexandria Forbes , Development Highlights , Janssen Pharmaceuticals , Frontotemporal Dementia , Gene Therapy , Riboswitch Gene Regulation Platform , Owned Gene Therapy Manufacturing Facility , Ireland Received , Private Securities Litigation Reform Act , Quarterly Report ,

MeiraGTx Reports Second Quarter 2023 Financial and Operational Results

Phase 3 LUMEOS clinical trial of botaretigene sparoparvovec (bota-vec, formerly AAV-RPGR) for the treatment of X-linked retinitis pigmentosa (XLRP) enrollment target has now been surpassedAnnounced positive clinical data from the completed AQUAx Phase 1 study of AAV2-hAQP1 for the treatment of grade 2/3 radiation-induced xerostomia (RIX), showing bilaterally treated participants reaching normal levels of whole saliva flow rate by 2 months post-treatment and persisting through the final Month 12 ....

City Of , United Kingdom , United States , Jason Braco , Association For Research , Lifesci Communications , American Society Of Gene , Meiragtx Holdings , Cell Therapy , Alexandria Forbes , Development Highlights , Anticipated Milestones , Induced Xerostomia , Owned Gene Therapy Manufacturing Facility , Received Commercial , Gene Regulation Platform , Vector Engineering , Private Securities Litigation Reform Act , Quarterly Report , Six Month Period Ended June , Gene Regulation , Gene Therapy , Clinical Programs , Clinical Stage , Clinical Trials ,